Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Safety and Immunogenicity of Anti–SARS-CoV-2 Messenger RNA Vaccines in Recipients of Solid Organ Transplants
Olivier Marion, Arnaud Del Bello, Florence Abravanel, et al.
Annals of Internal Medicine (2021) Vol. 174, Iss. 9, pp. 1336-1338
Open Access | Times Cited: 146

Showing 1-25 of 146 citing articles:

Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months
E G Levin, Yaniv Lustig, Carmit Cohen, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 24
Open Access | Times Cited: 1083
Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients
Nassim Kamar, Florence Abravanel, Olivier Marion, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 7, pp. 661-662
Open Access | Times Cited: 826
Association Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the US
Jing Sun, Qulu Zheng, Vithal Madhira, et al.
JAMA Internal Medicine (2021) Vol. 182, Iss. 2, pp. 153-153
Open Access | Times Cited: 238
Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review
Simon Galmiche, Liêm Binh Luong Nguyen, Éric Tartour, et al.
Clinical Microbiology and Infection (2021) Vol. 28, Iss. 2, pp. 163-177
Open Access | Times Cited: 175
Efficiency of a boost with a third dose of anti-SARS-CoV-2 messenger RNA-based vaccines in solid organ transplant recipients
Arnaud Del Bello, Florence Abravanel, Olivier Marion, et al.
American Journal of Transplantation (2021) Vol. 22, Iss. 1, pp. 322-323
Open Access | Times Cited: 128
Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients With CKD
Edward J Carr, Andreas Kronbichler, Matthew Graham‐Brown, et al.
Kidney International Reports (2021) Vol. 6, Iss. 9, pp. 2292-2304
Open Access | Times Cited: 107
COVID-19 Vaccine Booster Hesitancy (VBH) of Healthcare Workers in Czechia: National Cross-Sectional Study
Miloslav Klugar, Abanoub Riad, Lekshmi Mohanan, et al.
Vaccines (2021) Vol. 9, Iss. 12, pp. 1437-1437
Open Access | Times Cited: 106
Immunogenicity and Risk Factors Associated With Poor Humoral Immune Response of SARS-CoV-2 Vaccines in Recipients of Solid Organ Transplant
Kasama Manothummetha, Nipat Chuleerarux, Anawin Sanguankeo, et al.
JAMA Network Open (2022) Vol. 5, Iss. 4, pp. e226822-e226822
Open Access | Times Cited: 87
The Global Impact of COVID-19 on Solid Organ Transplantation: Two Years Into a Pandemic
Ailish Nimmo, Dale Gardiner, Ines Ushiro‐Lumb, et al.
Transplantation (2022) Vol. 106, Iss. 7, pp. 1312-1329
Open Access | Times Cited: 76
High immunogenicity of a messenger RNA-based vaccine against SARS-CoV-2 in chronic dialysis patients
Nathalie Longlune, Marie Béatrice Nogier, Marcel Miédougé, et al.
Nephrology Dialysis Transplantation (2021) Vol. 36, Iss. 9, pp. 1704-1709
Open Access | Times Cited: 98
Immunological responses to SARS-CoV-2 vaccines in kidney transplant recipients
Maria Prendecki, Tina Thomson, Candice Clarke, et al.
The Lancet (2021) Vol. 398, Iss. 10310, pp. 1482-1484
Open Access | Times Cited: 65
Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper
Thomas Marjot, Christiane S. Eberhardt, Tobias Boettler, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 4, pp. 1161-1197
Open Access | Times Cited: 62
A third injection of the BNT162b2 mRNA COVID-19 vaccine in kidney transplant recipients improves the humoral immune response
Christophe Masset, Clarisse Kerleau, Claire Garandeau, et al.
Kidney International (2021) Vol. 100, Iss. 5, pp. 1132-1135
Open Access | Times Cited: 61
Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T-cell Therapy
Roni Tamari, Ioannis Politikos, David A. Knorr, et al.
Blood Cancer Discovery (2021) Vol. 2, Iss. 6, pp. 577-585
Open Access | Times Cited: 58
Immunogenicity of COVID-19 vaccines in solid organ transplant recipients: a systematic review and meta-analysis
Xinpei Chen, De Luo, Bingjie Mei, et al.
Clinical Microbiology and Infection (2022) Vol. 29, Iss. 4, pp. 441-456
Open Access | Times Cited: 44
Anti-SARS-CoV-2 spike protein and neutralizing antibodies at 1 and 3 months after three doses of SARS-CoV-2 vaccine in a large cohort of solid organ transplant patients
Nassim Kamar, Florence Abravanel, Olivier Marion, et al.
American Journal of Transplantation (2022) Vol. 22, Iss. 5, pp. 1467-1474
Open Access | Times Cited: 40
Efficacy and Safety of Third Dose of the COVID-19 Vaccine among Solid Organ Transplant Recipients: A Systemic Review and Meta-Analysis
Orly Efros, Roi Anteby, Mirit Halfon, et al.
Vaccines (2022) Vol. 10, Iss. 1, pp. 95-95
Open Access | Times Cited: 37
Decline in Antibody Concentration 6 Months After Two Doses of SARS-CoV-2 BNT162b2 Vaccine in Solid Organ Transplant Recipients and Healthy Controls
Sebastian Rask Hamm, Dina Leth Møller, Laura Pérez‐Alós, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 37
COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis
Ka Shing Cheung, Chiu Hang Mok, Xianhua Mao, et al.
Clinical and Molecular Hepatology (2022) Vol. 28, Iss. 4, pp. 890-911
Open Access | Times Cited: 37
Impact of age and comorbidities on SARS-CoV-2 vaccine-induced T cell immunity
Lisa Loksø Dietz, Anna Karina Juhl, Ole S. Søgaard, et al.
Communications Medicine (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 28
A Retrospective Analysis of COVID-19 mRNA Vaccine Breakthrough Infections – Risk Factors and Vaccine Effectiveness
Cong Liu, Junghwan Lee, Casey Ta, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 46
Efficacy and safety of the BNT162b2 mRNA COVID-19 vaccine in participants with a history of cancer: subgroup analysis of a global phase 3 randomized clinical trial
Stephen J. Thomas, John L. Perez, Stephen Lockhart, et al.
Vaccine (2021) Vol. 40, Iss. 10, pp. 1483-1492
Open Access | Times Cited: 46
COVID‐19 vaccination in patients with heart failure: a position paper of the Heart Failure Association of the European Society of Cardiology
Giuseppe Rosano, Ewa A. Jankowska, Robin Ray, et al.
European Journal of Heart Failure (2021) Vol. 23, Iss. 11, pp. 1806-1818
Open Access | Times Cited: 45
Coordinated cellular and humoral immune responses after two‐dose SARS‐CoV2 mRNA vaccination in liver transplant recipients
Gianpiero D’Offizi, Chiara Agrati, Ubaldo Visco‐Comandini, et al.
Liver International (2021) Vol. 42, Iss. 1, pp. 180-186
Open Access | Times Cited: 41
COVID-19 Disease Severity among People with HIV Infection or Solid Organ Transplant in the United States: A Nationally-representative, Multicenter, Observational Cohort Study
Jing Sun, Rena C. Patel, Qulu Zheng, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 40
Page 1 - Next Page

Scroll to top